TY - JOUR
T1 - Engineering a Fusion Protein Biomaterial Based on SpyTag/SpyCatcher Bioconjugation of Elastin and Collagen Synthetic Proteins
AU - Toledo-Garcia, Pedro
AU - Argüelles-Luyo, César
AU - Donayre-Torres, Alberto
N1 - Publisher Copyright:
© 2025 The Authors. Published by American Chemical Society.
PY - 2025/4/29
Y1 - 2025/4/29
N2 - Bioconjugation enables the precise control of structural and functional properties in the development of biomaterials by facilitating the covalent linkage of functional biomolecules. In this study, we developed and optimized a bioconjugation strategy to fuse recombinant proteins resembling collagen and elastin using the SpyTag/SpyCatcher system. The proteins were successfully expressed in Escherichia coli strain JM109(DE3) and efficiently purified via histidine affinity chromatography, attaining concentrations of 146.6 μg/mL for Scl2-ST and 124.3 μg/mL for ELP-SC. Following this, we optimized the in vitro bioconjugation process by adjusting the molar ratio of Scl2-ST to ELP-SC to 2:1, maximizing the yield of the fusion protein through the application of diafiltration. Morphological characterization of the fusion and its components was conducted using scanning electron microscopy, confirming that Scl2-ST retained its triple-helical structure, elastin-like polypeptide exhibited self-aggregation, and the fused protein formed a porous network. Our results indicate promising opportunities for scalability innovations, particularly through bioreactor-based production of the bioconjugation, which could allow for the full characterization and further development of this novel biomaterial.
AB - Bioconjugation enables the precise control of structural and functional properties in the development of biomaterials by facilitating the covalent linkage of functional biomolecules. In this study, we developed and optimized a bioconjugation strategy to fuse recombinant proteins resembling collagen and elastin using the SpyTag/SpyCatcher system. The proteins were successfully expressed in Escherichia coli strain JM109(DE3) and efficiently purified via histidine affinity chromatography, attaining concentrations of 146.6 μg/mL for Scl2-ST and 124.3 μg/mL for ELP-SC. Following this, we optimized the in vitro bioconjugation process by adjusting the molar ratio of Scl2-ST to ELP-SC to 2:1, maximizing the yield of the fusion protein through the application of diafiltration. Morphological characterization of the fusion and its components was conducted using scanning electron microscopy, confirming that Scl2-ST retained its triple-helical structure, elastin-like polypeptide exhibited self-aggregation, and the fused protein formed a porous network. Our results indicate promising opportunities for scalability innovations, particularly through bioreactor-based production of the bioconjugation, which could allow for the full characterization and further development of this novel biomaterial.
UR - http://www.scopus.com/inward/record.url?scp=105003863925&partnerID=8YFLogxK
U2 - 10.1021/acsomega.4c10313
DO - 10.1021/acsomega.4c10313
M3 - Article
C2 - 40321559
AN - SCOPUS:105003863925
SN - 2470-1343
VL - 10
SP - 16245
EP - 16256
JO - ACS Omega
JF - ACS Omega
IS - 16
ER -